Brainstem toxicity after proton or photon therapy in children and young adults with localized intracranial ependymoma: A French retrospective study

Authors: Dalmasso, Céline, Alapetite, Claire, Bolle, Stéphanie, Goudjil, Farid, Lusque, Amélie, Desrousseaux, Jacques, Claude, Line, Doyen, Jérome, Bernier-Chastagner, Valérie, Ducassou, Anne, Sevely, Annick, Roques, Margaux, Tensaouti, Fatima, Laprie, Anne

Source: In Radiotherapy and Oncology May 2024 194

PD-1 inhibitors might limit the development of brain metastases in patients with advanced melanoma.

Authors: Marcaillou, Marion, Linder, Clara, Chaltiel, Léonor, Sibaud, Vincent, Pagès, Cécile, Modesto, Anouchka, Chira, Ciprian, Dalmasso, Céline, Boulinguez, Serge, Bedane, Christophe, Meyer, Nicolas

Source: Melanoma Research; Dec2020, Vol. 30 Issue 6, p580-589, 10p

Survival estimation of melanoma patients with brain metastasis using the Melanoma-molGPA score: external validation from a French cohort.

Authors: Dalmasso, Céline, Pagès, Cécile, Chaltiel, Léonor, Brun, Aurore, Sibaud, Vincent, Boulinguez, Serge, Chira, Ciprian, Moyal, Elizabeth, Lubrano, Vincent, Meyer, Nicolas, Modesto, Anouchka

Source: Melanoma Research; Oct2020, Vol. 30 Issue 5, p472-476, 5p

Intracranial Treatment in Melanoma Patients with Brain Metastasis Is Associated with Improved Survival in the Era of Immunotherapy and Anti-BRAF Therapy.

Authors: Dalmasso, Céline¹ (AUTHOR) dalmasso.celine@iuct-oncopole.fr, Pagès, Cécile² (AUTHOR) pages.cecile@iuct-oncopole.fr, Chaltiel, Léonor³ (AUTHOR) chaltiel.leonor@iuct-oncopole.fr, Sibaud, Vincent² (AUTHOR) sibaud.vincent@iuct-oncopole.fr, Moyal, Elisabeth^1,4 (AUTHOR) moyal.elizabeth@iuct-oncopole.fr, Chira, Ciprian¹ (AUTHOR) chira.ciprian@iuct-oncopole.fr, Sol, Jean Christophe^4,5 (AUTHOR) ilatorzeff@clinique-pasteur.com, Latorzeff, Igor^4,6 (AUTHOR), Meyer, Nicolas^2,7 (AUTHOR) meyer.n@chu-toulouse.fr, Modesto, Anouchka¹ (AUTHOR) modesto.anouchka@iuct-oncopole.fr

Source: Cancers. Sep2021, Vol. 13 Issue 17, p4493. 1p.

Subject Terms: *STATISTICS, *IMMUNE checkpoint inhibitors, *GENETIC mutation, *CONFIDENCE intervals, *ACQUISITION of data methodology, *MELANOMA, *PROTEIN kinase inhibitors, *MULTIVARIATE analysis, *METASTASIS, *DISEASE incidence, *RETROSPECTIVE studies, *BRAIN tumors, *TREATMENT effectiveness, *CANCER patients, *SURVIVAL analysis (Biometry), *DESCRIPTIVE statistics, *MEDICAL records, *COMBINED modality therapy, *IMMUNOTHERAPY, *DRUG administration, *DRUG dosage, *THERAPEUTICS, *EVALUATION

Geographic Terms: FRANCE